Founders Financial Alliance LLC trimmed its holdings in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 4.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,174 shares of the company’s stock after selling 449 shares during the period. Founders Financial Alliance LLC’s holdings in BlackRock Health Sciences Trust were worth $412,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Stonebridge Capital Advisors LLC acquired a new position in shares of BlackRock Health Sciences Trust during the third quarter worth approximately $31,000. Farmers & Merchants Investments Inc. purchased a new stake in BlackRock Health Sciences Trust in the 4th quarter valued at $40,000. Truist Financial Corp bought a new position in BlackRock Health Sciences Trust during the 4th quarter valued at $213,000. HBK Sorce Advisory LLC lifted its stake in BlackRock Health Sciences Trust by 7.0% during the 3rd quarter. HBK Sorce Advisory LLC now owns 5,876 shares of the company’s stock valued at $230,000 after acquiring an additional 386 shares in the last quarter. Finally, L.M. Kohn & Company lifted its stake in BlackRock Health Sciences Trust by 9.9% during the 4th quarter. L.M. Kohn & Company now owns 7,782 shares of the company’s stock valued at $315,000 after acquiring an additional 704 shares in the last quarter.
BlackRock Health Sciences Trust Price Performance
NYSE:BME traded down $0.04 during trading hours on Friday, hitting $40.04. 22,644 shares of the company traded hands, compared to its average volume of 32,556. The firm’s 50-day simple moving average is $39.96 and its 200-day simple moving average is $40.36. BlackRock Health Sciences Trust has a one year low of $35.53 and a one year high of $42.86.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 5/20 – 5/24
- Stock Market Upgrades: What Are They?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- What Are the U.K. Market Holidays? How to Invest and Trade
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.